San Gerardo Hospital Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Monza Italy (1174)

Organization Overview

First Clinical Trial
2008
NCT01247857
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

ASST-Monza San Gerardo Hospital | Department of anesthesiology and resuscitation I, San Gerardo Hospital | San Gerardo Hospital, MB, Italy | University Hospital San Gerardo Monza, Italy

Active Ingredients

Drugs in Phase 4 Trials (1)

sevoflurane (ultane) (1 trial)

Drugs in Phase 3 Trials (3)

norepinephrine (levophed) (1 trial)

ropivacaine (naropin) (6 trials)

sodium chloride (3 trials)

Drugs in Phase 2 Trials (1)

durvalumab (imfinzi) (1 trial)

Drugs in Phase 1 Trials (1)

autologous mesenchymal stem cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Delirium (Phase 4)

Emergence Delirium (Phase 4)

Graft vs Host Disease (Phase 1)

Mesothelioma (Phase 2)

Ovarian Cysts (Phase 3)

Pain, Postoperative (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 6